| Bu Su | 08-Aug-24 | | NED | | |
| Chang Yim Yang | | | Sen Mgr | | |
| Chau Lai Ki | 31-Aug-26 | | CFO | | |
| 07-Nov-17 | | CoSec | | |
| Cheng Gary Faat Ting | 31-Aug-26 | | INED, ChAC | | |
| Chow Joseph Kwok Fai | 16-Dec-20 | | INED | | |
| Poon Michael Lai Yin | 31-Aug-26 | | CEO | | |
| 03-Aug-17 | | ED | | |
| Wang Yachun | 08-Jul-25 | | ChCC | | |
| 30-Jun-25 | | INED | | |
| Zhang Chunguang | 03-Aug-17 | | ED | | |
| Zhang Yujing | 29-Aug-25 | | Ch | | |
| 16-Apr-25 | | ED | | |
| Zhou Xunyong | 31-Aug-26 | | Ch, MbCC, ChNC, AuRep | | |
| 20-Nov-25 | | ED | | |
| Chau Lai Ki | 07-Nov-17 | 31-Aug-26 | FC | | Re-designated from a Financial Controller of the Company to the Chief Financial Officer of the Company. |
| Poon Michael Lai Yin | 03-Aug-17 | 31-Aug-26 | CFO | | Re-designated from the Chief Financial Officer to the Chief Executive Officer of the Company. |
| Tsui Wing Tak | 22-Jan-25 | 31-Aug-26 | INED | | He intended to devote more time to his other personal business and commitments. |
| Zhang Chunguang | 03-Aug-17 | 31-Aug-26 | CEO | | He intended to devote more time to focus on the management of the business of Shenzhen Huakang Bio-Medical Engineering Limited* (深圳華康生物醫學工程有限公司), which is an indirect wholly-owned subsidiary of the Company. |
| Tsui Wing Tak | 08-Jul-25 | 31-Aug-26 | ChAC | | He intended to devote more time to his other personal business and commitments. |
| Zhang Yujing | 29-Aug-25 | 31-Aug-26 | AuRep, ChNC | | Resigned; remains as an executive Director. |
| Zhou Xunyong | 11-Dec-25 | 31-Aug-26 | Co-Ch | | Re-designated from a Co-Chairman of the Board to the Chairman of the Board. |
| Tsui Wing Tak | | 31-Aug-26 | MbNC | | He intended to devote more time to his other personal business and commitments. |
| Zhang Yujing | | 31-Aug-26 | Co-Ch | | Resigned; remains as an executive Director. |
| Zhang Chunguang | | 31-Aug-26 | MbCC | | He intended to devote more time to focus on the management of the business of Shenzhen Huakang Bio-Medical Engineering Limited* (深圳華康生物醫學工程有限公司), which is an indirect wholly-owned subsidiary of the Company. |
| Xu Ming | 25-Oct-24 | 30-Mar-26 | NED | | Resigned to devote more time to his other personal business and commitments. |
| Zhang Shuguang | 03-Aug-17 | 29-Aug-25 | Ch, ED | | Mr. Zhang intended to devote more time to focus on the management of the business of the subsidiaries of the Company, rather than to focus on the Company’s executive functions. |
| 29-Aug-25 | ChNC, AuRep | | Mr. Zhang intended to devote more time to focus on the management of the business of the subsidiaries of the Company, rather than to focus on the Company’s executive functions. |
| Cheng Gary Faat Ting | 01-Sep-20 | 08-Jul-25 | INED | | Dr. Cheng intended to devote more time to his other business and personal commitments. |
| 08-Jul-25 | ChCC | | Dr. Cheng intended to devote more time to his other business and personal commitments. |
| He Jiaming | 14-Jan-20 | 16-Apr-25 | ED | | After discussion with the Board, Mr. He intended to devote more time to focus on the management of the business of the subsidiaries of the Company, rather than to focus on the Company’s executive functions. |
| Shih Mei Ling | 03-Dec-24 | 28-Feb-25 | INED | | Ms. Shih resigned as she intended to devote more time to her other personal business and commitments. |
| Chow Ching Man | 02-Aug-23 | 22-Jan-25 | INED | | Ms. Chow intended to devote more time to her other personal business and commitments. |
| 22-Jan-25 | MbAC, MbNC | | Ms. Chow intended to devote more time to her other personal business and commitments. |
| Chan Peter Kin Sang | 26-Nov-18 | 02-Apr-24 | INED | | |
| Yeung David Wai Chow | 26-Nov-18 | 16-Dec-20 | INED | | |
| Kwok Wilson Chi Shing | 26-Nov-18 | 01-Sep-20 | INED | | |
